Wiesweg, M., Alaffas, A., Rasokat, A., Saalfeld, F. C., Rost, M., Assmann, C., . . . Scheffler, M. (2025). Treatment sequences in BRAF-V600-mutated NSCLC: First-line targeted therapy versus first-line (chemo-) immunotherapy. Journal of thoracic oncology, 20(9), . https://doi.org/10.1016/j.jtho.2025.04.016
Chicago-Zitierstil (17. Ausg.)Wiesweg, Marcel, et al. "Treatment Sequences in BRAF-V600-mutated NSCLC: First-line Targeted Therapy Versus First-line (chemo-) Immunotherapy." Journal of Thoracic Oncology 20, no. 9 (2025). https://doi.org/10.1016/j.jtho.2025.04.016.
MLA-Zitierstil (9. Ausg.)Wiesweg, Marcel, et al. "Treatment Sequences in BRAF-V600-mutated NSCLC: First-line Targeted Therapy Versus First-line (chemo-) Immunotherapy." Journal of Thoracic Oncology, vol. 20, no. 9, 2025, https://doi.org/10.1016/j.jtho.2025.04.016.